Oct 1 will ther be a sales force reduction?

Quote




































Anonymous said:
The European approval is a game changer. Big positive development. The rest is yet another BS false rumor.
Click to expand...

The fact that JD, DD, PA, SP and BJ came in and have drove the stock down, means they know nothing about this market or what they are doing. I wonder if they will take pay cuts after the RIF?
 
























Well I have been here for 2 years, I met them and the results say they are in over their head , way over. I hope they had fun while it lasted. Just look at how fast they were all hired. And look at who couldn't cut it. Undoubtedly under qualified and hired in a crony vacuum. It's not what you know but who you know. In the end , justice always prevails. You cant go through the motions, clueless about how to get the job done and expect everything to be ok. All of this is the result of hiring the wrong people. At every level.
 






Anonymous said:
Well I have been here for 2 years, I met them and the results say they are in over their head , way over. I hope they had fun while it lasted. Just look at how fast they were all hired. And look at who couldn't cut it. Undoubtedly under qualified and hired in a crony vacuum. It's not what you know but who you know. In the end , justice always prevails. You cant go through the motions, clueless about how to get the job done and expect everything to be ok. All of this is the result of hiring the wrong people. At every level.
Click to expand...

Of course cronyism prevails. Look at who hired The wife murder, substance abuser Randolph Maidens and their former connections.
 












This same management team has successfully relaunched several drugs after slower starts. You do it once and you can do it again. Like riding a bicycle.

I fully realize that you have been posting here for 2 years, but have never worked for the company.

Provenge works - no doubt there. Terminal cancer patients live longer. This is not an acne cream. Our company will do well.
 












Anonymous said:
Very well said. A rarity here.
Click to expand...

The stock market disagrees with you. I know for a fact DD, PA, SP and BJ have not been to a small bio tech company, their inexperience is showing up here along with their bulling tactics. Think back 18 months when they got here. The stock was $13 dollars, its now $3. The facts speak for themselves
 






Anonymous said:
The stock market disagrees with you. I know for a fact DD, PA, SP and BJ have not been to a small bio tech company, their inexperience is showing up here along with their bulling tactics. Think back 18 months when they got here. The stock was $13 dollars, its now $3. The facts speak for themselves
Click to expand...

The stock was grossly overinflated. I don't pin that on the current mgmt team. The learning curve for a unique product like this is a long one. As was said earlier in the thread, the product works. NCCN gives it a category 1 rating. Patients survive longer, if you know how to read the studies and understand the science. Bottom line, patients need and deserve to have the chance to go on Provenge. Future cancer patients will benefit from the long learning curve that Dendreon is going through right now. It's a long term scenario, not for the faint of heart.

Stay concerned for the patients and everything else will fall into place! Those with the narrow minded focus on the stock price will get it over time. The science will play a major role in the treatment of several cancers and the stock price will eventually rise. The former is far more important to those on this message board compared to the latter.
 
























Top Bottom
Back
Quote